➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Boehringer Ingelheim
McKesson
Merck
Baxter
Harvard Business School

Last Updated: June 1, 2020

DrugPatentWatch Database Preview

Details for Patent: 9,757,552


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,757,552
Title:Applicator for inserting an implant
Abstract: The invention pertains to an applicator (1) for inserting an implant, in particular a rod-like implant (2) containing an active substance, under the skin of a human or animal, comprising a housing (3), a cannula (6), a cannula holder (9), an implant (2) accommodated inside the cannula (6) and/or the cannula holder (9), a protective cover (7) for the cannula (6), and a mechanism (22, 23, 7) which, at least after the cover (7) has been removed from the cannula (6), secures the implant (2) inside the cannula (6) and/or cannula holder (9). The mechanism (22, 23, 7) disengages the implant (2) during insertion of the cannula (6) or after the cannula (6) has been inserted. Substantially no lateral force will be exerted during the expelling of the implant from the cannula.
Inventor(s): Jansen; Willem (Lieshout, NL), Tak; Maurice Petrus Wilhelmus (Hengelo, NL), Vertegaal; Hendricus Johannes (Hengelo, NL), Van Der Graaf; Iris Epkjen Hobo (Deventer, NL)
Assignee: MERCK SHARP & DOHME B.V. (Haarlem, NL)
Application Number:11/795,805
Patent Claim Types:
see list of patent claims
Use; Delivery; Device;

Drugs Protected by US Patent 9,757,552

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Organon Usa Inc IMPLANON etonogestrel IMPLANT;IMPLANTATION 021529-001 Jul 17, 2006 DISCN No No   Start Trial   Start Trial Y PREVENTION OF PREGNANCY   Start Trial
Organon Usa Inc NEXPLANON etonogestrel IMPLANT;IMPLANTATION 021529-002 May 31, 2011 RX Yes Yes   Start Trial   Start Trial Y PREVENTION OF PREGNANCY   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 9,757,552

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
05100418Jan 24, 2005
PCT Information
PCT FiledJanuary 20, 2006PCT Application Number:PCT/EP2006/050346
PCT Publication Date:July 27, 2006PCT Publication Number: WO2006/077250

International Family Members for US Patent 9,757,552

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 055716   Start Trial
Australia 2006207455   Start Trial
Brazil PI0607013   Start Trial
Canada 2593849   Start Trial
China 101151062   Start Trial
European Patent Office 1841493   Start Trial
European Patent Office 3417905   Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Baxter
AstraZeneca
Mallinckrodt
Dow
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.